Physicians' Academy for Cardiovascular Education

Novel approaches in managing patients with HCM

10' education - Oct. 1, 2023 - Iacopo Olivotto, MD - Florence, Italy

Video navigation menu

  • Cardiac myosin inhibitors for obstructive HCM - ESC guidelines 1:10
  • Development of mavacamten 2:24
  • Next-in-class aficamten 4:59
  • Study results with mavacamten 5:30
  • Surgery in HCM 6:47
  • Non-obstructive HCM 7:30


Show transcript

Educational information

This lecture by Iacopo Olivotto was part of the EBAC-accredited symposium "Emerging perspectives in the diagnosis and management of hypertrophic cardiomyopathy" at the ESC congress 2023.


Prof. Iacopo Olivotto is Head of the Cardiology Unit at Meyer University Children Hospital and Professor of Cardiovascular Medicine at the University of Florence, Italy. His main clinical and research interests include various aspects of cardiomyopathies, with special focus on hypertrophic cardiomyopathy.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant from Bristol Myers Squibb.

View the slides of this presentation

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: